In colorectal cancer patients, a high density of cytotoxic CD8 + T cells in tumors is associated with better prognosis. Using a Stat3 loss-of-function approach in two wnt/b-catenin-dependent autochthonous models of sporadic intestinal tumorigenesis, we unravel a complex intracellular process in intestinal epithelial cells (IECs) that controls the induction of a CD8 + T cell based adaptive immune response. Elevated mitophagy in IECs causes iron(II)-accumulation in epithelial lysosomes, in turn, triggering lysosomal membrane permeabilization. Subsequent release of proteases into the cytoplasm augments MHC class I presentation and activation of CD8 + T cells via cross-dressing of dendritic cells. Thus, our findings highlight a so-far-unrecognized link between mitochondrial function, lysosomal integrity, and MHC class I presentation in IECs and suggest that therapies triggering mitophagy or inducing LMP in IECs may prove successful in shifting the balance toward anti-tumor immunity in colorectal cancer.
SUMMARY
In colorectal cancer patients, a high density of cytotoxic CD8 + T cells in tumors is associated with better prognosis. Using a Stat3 loss-of-function approach in two wnt/b-catenin-dependent autochthonous models of sporadic intestinal tumorigenesis, we unravel a complex intracellular process in intestinal epithelial cells (IECs) that controls the induction of a CD8 + T cell based adaptive immune response. Elevated mitophagy in IECs causes iron(II)-accumulation in epithelial lysosomes, in turn, triggering lysosomal membrane permeabilization. Subsequent release of proteases into the cytoplasm augments MHC class I presentation and activation of CD8 + T cells via cross-dressing of dendritic cells. Thus, our findings highlight a so-far-unrecognized link between mitochondrial function, lysosomal integrity, and MHC class I presentation in IECs and suggest that therapies triggering mitophagy or inducing LMP in IECs may prove successful in shifting the balance toward anti-tumor immunity in colorectal cancer.
INTRODUCTION
Colorectal cancer (CRC) belongs to a group of the most commonly diagnosed cancers in both men and women in the Western world (Siegel et al., 2016) . Activating mutations in the Wnt pathway that mostly affect APC or CTNNB1 are found in the majority of cases; however, apart from these, only a small number of additional genes are significantly mutated (Cancer Genome Atlas, 2012) . Instead, colorectal carcinogenesis depends on the close interaction of mutated tumor cells with their microenvironment (Grivennikov et al., 2010) . The presence of tumor-infiltrating T cells and, in particular, CD8 + T cells and increased interferon-gamma (IFNg) expression has prognostic relevance and is associated with prolonged survival, whereas a T helper 17 (Th17) T-cell-dominated immune response is associated with a worse outcome (Fridman et al., 2012) . While the clinical correlation between T cell infiltration and prognosis is undisputed and has led to the development of an immune score that can be employed to predict survival of CRC patients (Fridman et al., 2012) , less is known about the underlying cellular and molecular mechanisms that drive T cell polarization during intestinal carcinogenesis.
Activation of the transcription factor STAT3 has been documented in a wide range of tumors, including CRC (Bollrath and Greten, 2009 ). Multiple pathways, including receptor engagement by interleukin-6 (IL-6) family members, G-proteincoupled receptors, Toll-like receptors, and microRNAs, have been identified to activate JAK-STAT3 signaling in tumor cells and infiltrating immune cells (Yu et al., 2014) . This results in Y705 phosphorylation of STAT3 and nuclear translocation of STAT3 to drive transcription of genes involved in cell-cycle regulation, cell survival, cell migration, and, importantly, immunosuppression. In addition to phosphorylation of the Y705 residue of STAT3, phosphorylation can occur at serine-727 (S727) as a result of receptor engagement by various growth factors, such as epidermal growth factor (EGF), and signals that are transduced via the ERK-, p38-, JNK-, or PKCd-pathways (Decker and Kovarik, 2000) . Apart from STAT3's classical role as a transcription factor, non-canonical STAT3-dependent functions also have been proposed (Demaria et al., 2014; Gough et al., 2009; Wegrzyn et al., 2009) .
Autophagy represents an intracellular degradation process that encloses ubiquitinated proteins in vesicles termed ''autophagosomes,'' which subsequently fuse with lysosomes (Levine and Kroemer, 2008) . Besides its role as a response mechanism to cellular stress (e.g., during nutrient deprivation), autophagy also serves as the specific degradation mechanism of aged and/or damaged mitochondria, a process known as ''mitophagy.'' The kinase PINK1 binds to mitochondria with decreased membrane potential, the driving force of mitochondrial respiration, and thereby marks these to degradation via the autophagosomallysosomal pathway (Youle and Narendra, 2011) . Mitochondria are rich in iron-containing macromolecules; therefore, mitophagy, which leads to transfer of mitochondrial proteins into lysosomes, can contribute to lysosomal iron content, which is critical for their resistance to reactive oxygen species (Terman et al., 2010) .
The adaptive immune system relies on the presentation of cellular antigens by other cells on their surface via major histocompatibility complex (MHC) molecules. Whereas MHC class II molecules are present only on specialized antigen-presenting cells (mainly dendritic cells, DCs), MHC class I molecules are present on virtually all cells of mammalian organisms and can be recognized by CD8 + T cells. To bind to nascent MHC molecules, antigens have to be transported into the endoplasmic reticulum (ER) by the transmembrane transport system transporter associated with antigen presentation (TAP). In addition to a large body of evidence indicating that the proteasome is the origin of most antigens presented via MHC class I molecules, some evidence indicates that other proteases can contribute to antigen processing (Cruz et al., 2017; Mü nz, 2016; Rock et al., 2010) . Most notably, the lysosomal protease cathepsin S has been found to facilitate antigen generation in DCs in the endosomal-lysosomal compartment before being presented by MHC class I molecules (Hari et al., 2015; Shen et al., 2004) . In addition, in intestinal epithelial cells (IECs) as well as bone-marrow-derived antigen-presenting cells, cathepsin S is involved in antigen-presentation by MHC class II molecules, whereas cathepsin L is required for this in thymic cortical epithelial cells (Beers et al., 2005; Nakagawa et al., 1998) .
Apart from the ability of DCs to present peptide antigens from their cytoplasm, these cells are also involved in the uptake and processing of extracellular antigens with MHC class I molecules to CD8 + T cells by cross presentation (Cruz et al., 2017) .
Recently, it was noted that, in addition to foreign protein, DCs can also take up complete antigen-MHC class I (and II) complexes and present them to T cells, a process termed ''crossdressing'' (Nakayama, 2015) . This process has been implicated in anti-tumor immunity as well as anti-viral host defense (Nakayama, 2015) .
RESULTS

Loss of Stat3 in IECs Prevents Sporadic Tumorigenesis and Causes Infiltration of CD8+ T Cells during Tumor Initiation
Stat3 flox and Stat3 DIEC mice were subjected to 6 weekly injections of the somatic mutagen azoxymethane (AOM) and tumor development was examined 18 weeks later. While AOM induces oncogenic point mutations in b-catenin and led to development of tubular adenomas in the colons of 100% of Stat3-proficient (Stat3 flox ) animals, tumor formation was completely abolished in mice where Stat3 was deleted in IECs ( Figures 1A-1C) . Strikingly, the absence of Stat3 also prevented formation of pre-neoplastic foci which still occurred in these mice when challenged with AOM in the context of chronic inflammation during CAC Figure 1H ) and increased Il12 mRNA expression ( Figure 1I ) in the colonic lamina propria at an early time point in the model when first pre-neoplastic aberrant crypt foci (ACF) were detectable in both genotypes ( Figure 1G ; data not shown). This raised the possibility that AOM exposure triggered an adaptive immune response against mutagenized cell in Stat3 DIEC mice, thereby preventing their subsequent outgrowth into macroscopic colonic tumors. This finding is in line with a recent report demonstrating that CD8 + T cells can be stimulated by retinoic acid in vivo and, in doing so, can contribute to controlling AOM/DSS-induced tumor growth (Bhattacharya et al., 2016) . To distinguish whether an underlying mechanism is dependent on the mutagenic effect of AOM in IECs or the influence of mutated IECs on their cellular environment, we utilized villincreER T2 /Ctnnb loxEx3/WT mice, termed ''b-cat c.a. ,'' as a defined genetic model for oncogenic activation of the wnt pathway. This model confers IEC-specific and tamoxifen-induced expression of an exon-3-deleted-and thereby stabilized form ofb-catenin. Accordingly, b-cat c.a. mice mimic the AOM-induced missense mutation in exon 3 of Ctnnb that results in stabilization of the corresponding protein and aberrant activation of the wnt/b-catenin pathway (Greten et al., 2004) mice within $4 weeks after oral tamoxifen application 
/Stat3
DIEC mice; median survival of heterozygous b-cat c.a. /Stat3 +/DIEC mice: 22 days; n R 10; p < 0.001) ( Figure 1N ). We did not detect any evidence for improved differentiation or changes in proliferation of Stat3-deficient b-cat c.a.
IECs ( Figures S1A-S1H ), yet a higher villus/crypt ratio indicated a block in crypt expansion in b-cat c.a.
DIEC mice compared to Stat3-proficient controls ( Figure S1G ). Moreover, b-cat c.a.
/
Stat3
DIEC mice were characterized by a marked accumulation 
/Stat3
DIEC mice when compared to their Stat3 proficient counterparts ( Figure 2E ). These findings were further corroborated by fluorescence-activated cell sorting (FACS) analysis, which revealed a marked increase of CD3 + T cells in the lamina propria of b-cat Figure 2M ). In contrast, other notable immune cell populations were unchanged ( Figures 2N-2P ). In addition, we could detect a number of T cell related chemokines, most notably the IFNg-inducible chemokines CXCL-9, CXCL-10, and CXCL-11, to be upregulated in Stat3-deficient IECs during tumorigenesis ( Figure 2R Figure 3F ).
To functionally confirm that the survival advantage of b-cat c.a.
/
Stat3
DIEC mice was indeed dependent on the observed adaptive immune response rather than on IEC-specific cell autonomous effects such as proliferation, we either depleted CD8 + T cells using a neutralizing antibody or CD11c + DCs using CD11c-DTR mice (Jung et al., 2002 
/
Stat3
DIEC animals, Figure 3G and 3H). A comparable reduction of survival was also observed in b-cat c.a.
/Stat3
DIEC
/Ifng
À/À compound mutants, with a median survival of 23 days ( Figure 3I ). Collectively, these data strongly suggest that IEC-specific Stat3 activation precludes the generation of an effective CD8 + T celldependent immune response during the tumor initiation phase.
CD8 + T Cell Activation Is a Consequence of Lysosomal
Membrane Permeabilization
Having established the consequence of Stat3 deficiency in IECs during intestinal tumor initiation, we aimed to identify the responsible mechanism that prevented CD11c + DC and T cell activation. In fully malignant murine colon cancer cells or B16 melanoma cells expression of dominant negative Stat3 increases expression of pro-inflammatory cytokines, including tumor necrosis factor alpha (TNF-a), IL-6, CCL5, CXCL10, and IFNb, which triggers CD8 + T cell activation (Wang et al., 2004) . 
/
Stat3
DIEC mice when stained for LAMP2 ( Figures 4A and 4B ), which prompted us to examine lysosomal function. Lysosomal membrane permeabilization (LMP) in response to the acute cellular stress commonly elicited in mutagenized cells, leads to the release of cathepsins from lysosomes into the cytosol (Boya and Kroemer, 2008) . While total expression of cathepsins S, L, and B and of the lysosomal protease inhibitor cystatin C remained unaffected in IECs of b-cat c.a.
/Stat3
DIEC mice ( Figures  S3B and S3C ), proteases accumulated in cytoplasmic fractions of these cells presumably in response to increased release from lysosomes ( Figures 4C-4E ). Importantly, administration of the membrane permeable pan-cysteine protease inhibitor E64d prevented upregulation of Ifng gene expression in both b-cat c.a. and b-cat c.a. /Stat3 DIEC mice ( Figure 4F ), as well as IEC apoptosis ( Figure S3D ), supporting the notion that lysosomal proteases play an important role in CD8 + T cell activation. To examine whether LMP was essential in this context and whether such immune cell activation could also be elicited in Stat3-proficient IECs, we treated b-cat c.a. mice with chloroquine, a well-known inducer of LMP (Boya et al., 2003) . Indeed, chloroquine triggered release of cathepsins from lysosomes in b-catenin mutant IECs ( Figure 4G ) and caused accumulation of CD3 + T cells in the lamina propria of b-cat c.a. mice ( Figures 4H and 4I ) as well as supporting the notion that LMP-dependent protease release may be involved in antigen processing in epithelial cells. Indeed, when H 2 O 2 challenged OVA-CMT Stat3KD or OVA-CMT scr cells were co-cultured with MACS-purified OT-I CD8 + T cells in the absence of CD11c + DCs, this was sufficient to elicit IFNg secretion ( Figure 5F ), yet IFNg production was greatly enhanced when increasing numbers of CD11c + DCs were added ( Figure 5G) suggesting the transfer and presentation of MHC class I molecules via cross-dressing (Nakayama, 2015) rather than crosspresentation. To examine this possibility, we co-cultured ovalbumin-expressing CT26 colon tumor cells of BALB/c origin (OVA-CT26
Stat3KD
and OVA-CT26 scr ) or haplo-identical OVA-CMT Stat3KD and OVA-CMT scr together with C57BL/6-derived DCs from WT or Tap1-deficient mice along with OT-I CD8 T cells ( Figure 5H ). In the presence of BALB/c CT26 cells no OT-I T cell activation could be observed regardless of whether or not CT26 cells had been pre-treated with H 2 O 2 . Instead, T cell activation was only triggered by OVA-CMT cells, yet absence of Tap1 in DCs did not affect IFNg release (Figure 5J) , supporting the notion that T cell activation occurred independently of cross presentation. In contrast, knockdown of Tap1 in tumor cells prevented IFNg production by OT-I cells ( Figures 5K and S4A ), providing further evidence that antigenprocessing can occur directly in tumor cells. This was further supported when addition of DCs derived from BALB/c mice enhanced the stimulation of OT-I T cells in a dose-dependent manner when cultured together with OVA-CMT Stat3KD cells but not with OVA-CMT scr cells ( Figure 5L ). Moreover, when we cocultured BALB/c CT26 cells with C57BL/6 splenocytes, we could detect the presence of the BALB/c MHC class I allele D d on C57BL/6 DCs. The MHC transfer was enhanced by H 2 O 2 pretreatment of tumor cells, which, again, occurred independent of Tap1 expression in DCs ( Figures 5M and 5N ). Collectively, these results further strongly supported our hypothesis that Stat3-deficient tumor cells can directly process antigens in a LMP-dependent manner and cross-dress DCs to induce an effective CD8 + T cell response. Previously, it had been suggested that cathepsin S is engaged in MHC class II-mediated antigen presentation in IECs in vivo, whereas cathepsin L enables this in thymic cortical epithelial cells (Beers et al., 2005; Nakagawa et al., 1998; Shen et al., 2004) . To functionally examine whether cathepsin S, cathepsin L, or alterna- 
/Stat3
DIEC mice ( Figure S4D ). Importantly, we could not detect reduced protease activity in IECs of these mice when using the cathepsin substrate z-Leu-Arg-AMC ( Figure S4E ), indicating that in vivo the absence of cathepsin S and L could be compensated by other cysteine proteases as suggested in a murine pancreatic neuroendocrine tumor model (Akkari et al., 2016) .
Enhanced Mitophagy Leads to Iron(II) Accumulation in Lysosomes, thereby Triggering the Fenton Reaction Next, we aimed to address the mechanism causing LMP. LMP can be triggered by various stimuli, the most common being ROS-mediated lysosomal destabilization in the event of intralysosomal iron(II) accumulation (Boya and Kroemer, 2008) . During the Fenton reaction iron(II) catalyzes the conversion of H 2 O 2 into highly reactive hydroxyl and hydroperoxyl radicals (Winterbourn, 1995) . Oncogenic wnt activation triggers ROS production in IECs (Myant et al., 2013) , and, using the fluorescent Fe 2+ -specific probe IP-1 (Au-Yeung et al., 2013), we confirmed enhanced iron(II) accumulation in Stat3-deficient CMT93 cells ( Figures  6A-6D ). The signal of the iron probe IP-1 co-localized with LysoTracker fluorescence, confirming lysosomes as the predominant intracellular site of iron(II) accumulation in OVA-CMT cells ( Figures S5A-S5F ). However, we were not able to detect significant alterations in expression of genes coding for proteins involved in iron uptake ( Figure S5G ). Instead, we observed an increased presence of components of the mitochondrial oxidative phosphorylation system (COXII) in lysosomes of OVA-CMT Stat3KD cells ( Figures 6E-6H , S5H, and S5I). This was suggestive of enhanced mitophagy, a process selectively eliminating damaged or excessive mitochondria by the autophagic pathway as the transfer of iron-containing electron transporting complexes to lysosomes results in intralysosomal iron(II) accumulation (Terman et al., 2006; Youle and Narendra, 2011) . Interestingly, serine-phosphorylated Stat3 had been suggested to be involved in mitochondrial function to preserve oxidative phosphorylation in cardiac and nerve cells as well as RAS-transformed tumor cells (Gough et al., 2009; Wegrzyn et al., 2009 ). However, a transcriptionally constitutive active Stat3 (Stat3C) induces a metabolic switch toward aerobic glycolysis (Demaria et al., 2010) in a Hif1a-dependent manner, thereby eliciting the Warburg effect commonly described in cancers (Warburg et al., 1924) . In Stat3-deficient CMT93 cells we observed an increased basal and maximal oxygen consumption rate, decreased glucose-uptake and increased ATP levels (Figures 6I-6L and S5J), suggesting enhanced oxidative phosphorylation. In line with this notion, OVA-CMT Stat3KD cells proliferated significantly more in carbohydrate-deficient medium, or in the presence of the glycolysis inhibitors bromopyruvate or deoxyglucose, or when cultured in galactose, which all require mitochondrial activity to yield a positive energy balance but proliferated indifferently in the presence of glucose ( Figure S5K ). Staining with MitoTracker indicated an elevated number of mitochondria in OVA-CMT Stat3KD cells while at the same time the mitochondrial membrane potential was decreased in a larger proportion of these cells ( Figures 6M and 6N) . Collectively, these data suggested a higher turnover of mitochondria in Stat3-deficient cells, which was supported by flow cytometry after labeling OVA-CMT scr and OVA-CMT Because the additional inactivation of the S727 phosphorylation site (MLS-Stat3Y705F/S727A) blocked induction of LMP to a lesser extent than the other mutants, we speculate LMP was prevented by S727 phosphorylated Stat3 in mitochondria rather than Stat3-dependent transcription ( Figure 6P ). Accordingly, expression levels of Stat3-dependent genes involved in glycolysis or mitochondrial respiration (Demaria et al., 2010) were not markedly changed in OVA-CMT Stat3KD cells ( Figure S5L ).
To confirm the functional relevance of intralysosomal iron(II) accumulation for enhanced LMP in OVA-CMT Stat3KD cells, we treated CMT cells with the iron chelator deferoxamine (DFO) prior to the H 2 O 2 challenge, and this was indeed sufficient to prevent LMP ( Figures 7A and S6A-S6H) . The direct involvement of mitophagy in lysosomal iron accumulation, as well as T cell activation, was demonstrated by the finding, that RNAi-mediated gene knockdown of Pink1, a kinase responsible for the degradation of damaged mitochondria in the Pink1-Parkin pathway, in OVA-CMT Stat3KD cells markedly reduced lysosomal iron levels ( Figures S6I-S6M) , and prevented IFNg production in the OT-I co-culture system ( Figure 7B ). Moreover, pre-treatment of CMT93-cells with antimycin A or rotenone, which inhibit complex III and I of the respiratory chain, respectively, induce mitophagy (Fang et al., 2014) and increase the lysosomal iron(II) load ( Figures S6N-S6P ), thus sensitizing CMT93 cells to H 2 O 2 -induced LMP, which could be prevented by DFO ( Figure S6Q ). In line with improved oxidative phosphorylation in Stat3-deficient CMT cells in culture, in IECs of b-cat c.a.
DIEC we also detected elevated citrate synthase activity and an increased NAD + /NADH ratio (Figures 7C and 7D) . Expression of genes controlling glycolysis was unchanged ( Figure S6R 
DIEC mice ( Figure 7L ) and prevented prolonged survival of b-cat c.a.
DIEC mice ( Figure 7M ), thus further supporting the notion that accumulation of intralysosomal iron(II) was essential for the observed anti-tumor cell immune phenotype in these animals. In contrast, pharmacological suppression of autophagy using either 3-methyladenine or genetic ablation of Atg7 did not prevent IFNg upregulation in lamina propria of b-cat c.a.
DIEC mice but, instead, increased it even further ( Figures S6U and S6V) .
A newly established immune score based on the presence of different T cell subsets can efficiently predict tumor recurrence in CRC patients (Fridman et al., 2012) . In particular the presence of CD8 + T cells and high IFNg expression are associated with a better prognosis. Therefore, we examined whether STAT3 activation was involved in this phenomenon. Indeed, when we analyzed CRC biopsies, we found a significant inverse correlation between the accumulation of S727-phosphorylated STAT3 in tumor epithelia and the frequency of infiltrating CD8 + T cells ( Figures 7N-7R ) suggesting that STAT3 may also be functionally involved in the suppression of CD8 + T cell recruitment in human CRC.
DISCUSSION
Here, we have identified a so far unrecognized complex multistep process linking altered mitochondrial function and antigen presentation in IECs. By triggering mitophagy and increasing the amount of intralysosomal ferrous iron lysosomes are sensitized for the induction of LMP via the Fenton reaction. As a consequence cathepsins are released into the cytoplasm, enabling antigen processing directly in IECs. While we have discovered this connection in the context of Stat3 deletion, this mechanism is not strictly Stat3-dependent considering that LMP can be pharmacologically induced by chloroquine in a Stat3 WT background, thus suggesting a previously unrecognized role for lysosomes in regulating the immunogenicity of malignant transformed epithelial cells. Knockdown of both cathepsin S and cathepsin L could prevent OT-I T cell activation ex vivo, yet the absence of cathepsin S and cathepsin L could be compensated by other proteases in vivo. This suggests that not only one single cathepsin is involved in antigen presentation in IECs but also several proteases have the capacity to process the relevant antigen in vivo. Nevertheless, our data underscore the importance of LMP in IECs for CD8 + T cell activation since prevention of LMP by iron chelation was equally effective in suppressing IFNg upregulation as blockade of protease activity using E64d. Whether only the release of cathepsins to the cytoplasm or also cell death of IECs, which is usually associated with LMP induction (Boya and Kroemer, 2008) , contributes to enhanced T cell activation still has to be determined. Our data support the concept of cross-dressing (Nakayama, 2015) and suggest that the capacity of DCs to cross present is not essential for T cell activation in this scenario. Most likely, however, DCs are still required to provide essential co-stimulatory signals and indeed in vivo proper T cell activation by cross-dressing depends on the presence of DCs (Cerovic et al., 2015) . Interestingly, chloroquine-induced LMP in b-cat c.a.
mice IECs extended survival more efficiently than loss of Stat3 in IECs. Chloroquine can enhance human CD8 + T cell responses against soluble antigens by inhibiting endosomal acidification in DCs (Accapezzato et al., 2005) . Therefore, we cannot rule out that apart from affecting LMP in IECs some of the substantial tumor suppression is mediated by chloroquine's ability to influence endosomes in DCs as well.
In addition to controlling the transcription of a wide range of genes involved in cell proliferation and survival (Bollrath and Greten, 2009 ), Stat3 has been suggested to confer transcription-independent functions including the regulation of mitochondrial activity (Meier and Larner, 2014) . Indeed, mitochondrial Stat3 has been associated with decreased ETC activity, mainly complexes I, II, and V (Gough et al., 2009; Wegrzyn et al., 2009) . Further studies showed that Stat3 deficiency decreased activity in complexes III and IV (Meier and Larner, 2014) . In contrast, a constitutively active form of Stat3 (Stat3-C) supports a shift from oxidative phosphorylation toward glycolysis (Warburg effect) in mouse embryonic fibroblasts (MEFs) (Demaria et al., 2010) . That the latter phenotype is at least in part dependent on Y705 phosphorylation and nuclear functions of Stat3 highlights the pleiotropic role of Stat3 in mitochondrial activity and illustrates that actions of Stat3 in the mitochondria greatly vary between types of cells and experimental systems. The relative contribution of mitochondrial Stat3 to a given response probably most likely depends on the relative contribution of nuclear Stat3 in the particular context. Cancer-cell-generated lactate is now considered a critical immune suppressive metabolite and reducing lactate production by blocking glycolysis or direct inhibition of LDH-A has been suggested to restore physiological T cell function (Choi et al., 2013) . Our data suggest that in addition to inhibiting lactate production enhanced oxidative phosphorylation may trigger mitophagy, which would stimulate antigen processing thus further contributing to improved intestinal tumor suppressive immune function. Interestingly, the mitochondrial phenotype of Stat3-deficient cells comprising more mitochondria and enhanced oxidative phosphorylation does not match those typically of cells undergoing mitophagy. However, the fact that knockdown of Pink1 prevents LMP and CD8 + T cell activation strongly supports a contribution of mitophagy even though also mitophagy-independent functions of PINK1 have been described (Matheoud et al., 2016) . Thus, it will be of great interest to define the exact molecular alterations in Stat3-deficient mitochondria causing this particular phenotype. Our findings may provide the basis for novel therapeutic strategies that exploit anti-tumor immunity in CRC patients. These could encompass therapies interfering with mitochondrial function, thereby triggering mitophagy and the release of LMPinducing compounds. Compounds directed against Stat3 or presumably its upstream Jak tyrosine kinases or chloroquine might be good candidates to examine in this context.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice Stat3 DIEC mice have been described previously Takeda et al., 1998) . Ctnnb loxEx3/wt mice (Harada et al., 1999 ) were crossed to villin-creER T2 (el Marjou et al., 2004) mice to obtain b-cat c.a. mice. These were intercrossed with Stat3 F/F , Ctss À/À (Shi et al., 1999) , Ctsl F/F (Tholen et al., 2014) , Atg7 F/F (Komatsu et al., 2005) or ROSAOVA (Sandhu et al., 2011) animals to obtain the respective compound mutants. All mice were kept on a mixed genetic background. OT-I, Tap1 À/À , Ifng À/À mice and CD11c-DTR mice were obtained from Jackson Laboratories (Bar Harbor, USA). Appropriate littermate controls were used in all experiments. Age and sex-matched cohorts comprised of male and female mice at 6 to 12 weeks of age were used for experiments. All mice were kept on a 12-hour light/dark cycle in individually ventilated cages in specific pathogen-free facilities at Klinikum rechts der Isar, Munich and the Georg-Speyer-Haus, Frankfurt/Main, with chow (standard formulation) and water supply ad libitum. All procedures were reviewed and approved by the Regierung of Oberbayern or the Regierungsprä sidium Darmstadt, respectively. In general, mice were housed in groups of 3-5 mice per cage, unless experimental procedures (e.g., supplemented chow) or individual behavior (e.g., fighting) required single housing.
Human Samples
Human tumor samples were obtained from the tumor bank at the Institute of Pathology at Klinikum rechts der Isar, Munich or the Victoria Cancer Biobank, Melbourne. Samples have been analyzed per case and no assignment to groups (e.g., sex, age) have been performed. All procedures were performed with the approval of the respective ethics committees of the Technical University of Munich and the Victoria Cancer Biobank on samples from subjects that had given their written informed consent.
METHOD DETAILS
In vivo analyses
To induce colon tumors mice were injected i.p. with azoxymethane (Sigma-Aldrich, St. Louis, USA) once a week for 6 weeks at 10 mg/kg. In villin-creER T2 mice deletion was induced by five daily oral administrations of 1 mg tamoxifen (Sigma-Aldrich) dissolved in an ethanol/oil mixture, or, in the case of AOM-treated OVA Vil or OVA Vil /Stat3 DIEC mice, administered by tamoxifen-containing chow (Genobios, Laval, France, dosage 400 mg/kg). Depletion of CD8 + T cells in b-cat c.a. and b-cat c.a. /Stat3 DIEC mice was achieved by i.p. injection of 150 mg anti-CD8-antibody (clone 2.43, BE0061, BioXCell, Lebanon, USA) in 100 ml PBS for 3 consecutive days prior to oral administration of tamoxifen for 5 days. After completion of tamoxifen-administration mice were again injected for 3 consecutive days with 150 mg of antibody. Then mice were injected every 7 days for 3 consecutive days. CD8-cell depletion was confirmed by flow cytometric analysis of splenocytes. For depletion of dendritic cells, bone marrow of CD11c-DTR-mice was isolated, cleared of + T cells and tail-vein injected into 9 Gy irradiated recipients. Mice were allowed to recover for 8 weeks and depletion of DC was carried out by i.p. injection 4 mg/kg bodyweight diphtheria toxin (Merck, Darmstadt, Germany) every second day. Chloroquine (Sigma-Aldrich) was i.p. injected at 60 mg/kg bodyweight in 0.9% NaCl-solution, 3-MA (Sigma-Aldrich) at 30 mg/kg bodyweight in PBS, daily starting upon induction of b-cat-activation. Deferoxamine (DFO) (Sigma-Aldrich) was dissolved in 0.9% NaCl-solution and injected i.p. at 400 mg/kg every other day starting upon induction of b-cat-activation, E64d (Santa Cruz Biotechnology, Dallas, USA) was dissolved in an ethanol/oil-mixture and applied as oral gavage at 5 mg/kg bodyweight daily starting upon induction of b-cat-activation. ACC (Sigma-Aldrich) was dissolved in the drinking water at 0.5% (w/v) and applied continously starting upon induction of b-cat-activation.
Protein Analysis and Immunohistochemistry
Paraffin sections (3 mm) were stained using standard immunohistochemical procedures. In order to isolate intestinal epithelial cells intestines have been opened longitudinally, cleared of mucus, cut into small pieces (approx. 5 mm) and incubated in PBS containing 5 mM EDTA and 2 mM DTT with gentle agitation at 37 C for 10 min. Epithelial cells were then separated from underlying tissue by heavy vortexing and subsequent centrifugation.
For extraction of cytosolic proteins pelleted cells were dissolved in extraction buffer (25 mg/ml digitonin, 250 mM sucrose, 20 mM HEPES, 10 mM KCl, 1.5 mM MgCl 2 , 1 mM EDTA, 1 mM EGTA, pH 7.5 (all purchased from Carl Roth, Karlsruhe, Germany or SigmaAldrich) and incubated for 15 min on ice. Heavy membrane particles were pelleted at 10.000 g for 10 min. and dissolved in modified RIPA buffer (50 mM Tris-HCl, 250 mM NaCl, 25 mM sodium pyrophosphate, 3 mM EDTA, 3 mM EGTA, 1% Triton-X, 0.5%, Igepal CA-630, 10% Glycerol, pH 7.5, all from Carl Roth or Sigma-Aldrich) and cleared of lipids by additional centrifugation at 17.000 g for 12 min. Protease inhibitor cocktail (Roche Diagnostics, Mannheim, Germany) was added according to the manufacturer's instructions. For whole cell extracts cells pelleted, dissolved in modified RIPA buffer as above and cleared of lipids by additional centrifugation at 17.000 g for 12 min in presence of protease inhibitors.
Antibodies used were anti-CD3 (IS503, Dako, Hamburg, Germany), IFNg (BAF485, R&D Systems, Minneapolis, USA), Y705-phosphorylated Stat3 (9145), S727-phosphorylated Stat3 (9134S), LC3 (2775) p-Drp1 (4494S) and cleaved Caspase-3 (9579, all Cell Signaling Technologies, Danvers, USA), p62 (GP62-C, Progen, Heidelberg, Germany), Stat3 (610190, BD, Franklin Lakes, USA), MHC class I (sc-59199), Cathepsin S (sc-6505), Gapdh (sc-32233, Santa Cruz), b-Actin (A4700, Sigma-Aldrich), Cathepsin B (ab58802), LAMP2 (ab13524, Abcam, Cambridge, UK) and COXII (55070-1-AP, Proteintech, Rosemont, USA). Biotinylated secondary antibodies were purchased from Vector Labs (Burlingame, USA). For human tissue, anti-CD8 (108M-96, Cell Marque, Rocklin, USA) and S727-phosphorylated-Stat3 (ab30647, Abcam) were used.
Immunofluorescent staining was performed on paraffin sections or Lab-Tek II Chamber slides (Thermo Fisher Scientific, Waltham, USA) using standard procedures and indicated primary antibodies. Secondary antibodies were fluorochrome-conjugated anti-rabbit IgG-Alexa Fluor 488 (A-21206, Thermo Fisher Scientific) and anti-rat IgG-Cy3 (Jackson Immunoresearch, West Grove, USA). For detection of mouse primary antibodies, the M.O.M. Fluorescein Kit (Vector Labs) was used according to the manufacturer's instructions. Where indicated slides were analyzed using a SP5 confocal laser scanning microscope (Leica, Wetzlar, Germany). Size of tumors was quantified by measuring the largest area of each tumor in serial sections (approx. 250 mm distance between single sections) using a AxioImager microscope and AxioVision software (Zeiss, Jena, Germany).
For electron microscopy tissue samples from small intestines were excised, fixed with 2.5% glutaraldehyde solution and processed according to standard procedures.
Isolation and analysis of lamina propria cells
For the isolation of lamina propria cells intestines of mice were opened longitudinally, cleared of mucus, chopped into small pieces and digested in supplemented RPMI (Thermo Fisher Scientific) containing 1 mg/ml Collagenase I (C0130, Sigma-Aldrich), 1 mg/ml Dispase II (Roche), 20 mg/ml DNase I, 10 mM HEPES, non-essential amino acids, Glutamine (all Sigma-Aldrich or Thermo Fisher Scientific) and 2% fetal calf serum (Thermo Fisher Scientific) for 15 -20 min. at 37 C while gently shaking. Liberated cells were collected and placed on ice. The digestion has been repeated for 2 additional times using fresh digestion medium. Following the third digestion step all fractions were combined and passed through a 70 mm strainer (BD). Flow cytometric analysis was performed on a Gallios flow cytometer (Beckman-Coulter, Brea, USA), FACSCalibur, FACSCantoII or LSRFortessa (all BD). The following fluorochrome-conjugated antibodies were used: CD3-Alexa Fluor 700 (56-0032), CD4-eFluor 450 (48-0042), CD8a-APC (17-0081), IFNg-PerCPCy5.5 (45-7311), CD11c-FITC (11-0114), CD11b-APC-eFluor 780 (47-0112), CD80-PE-Cy7 (25-0801-82), Gr-1-Alexa Fluor 700 , , all Thermo Fisher Scientific, Santa Cruz, USA), all BD) . Appropriate isotype control antibodies were purchased from Thermo Fisher Scientific. For intracellular staining cells were ex vivo restimulated in supplemented RPMI containing either 1 mg/ml ionomycin and 20 ng/ml phorbol-myristate-acetate (for T cells) or 0.1 mg/ml LPS (for DC, all Sigma-Aldrich) in presence of Golgi-Plug (BD) for 5 hr at 37 C. Cells were prestained with 0.5 mg/ml ethidium bromide monoazide (Sigma-Aldrich) for 15 min in bright light or Live/Dead Fixable Blue Dead Cell Stain Kit, fixed in IC-fixation buffer for 30 min on ice and stained in permeabilization buffer (all Thermo Fisher Scientific). SIINFEKL-MHCI-pentamer was purchased from ProImmune (Oxford, UK) and used according to the manufacturer's instructions.
FACS-sort has been performed on a FACSAria or FACSAria Fusion (all BD).
Cell culture and T cell activation assay Stat3 À/À mouse embryonic fibroblasts were provided by Thomas Decker and reconstituted with the indicated plasmids by retroviral transduction as described previously . The murine colon carcinoma cell lines CMT93 was obtained from ATCC. Cells were cultured under standard conditions using Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% FCS and 1% Penicillin-Streptomycin. CMT93 cells were transfected with an expression vector encoding chicken ovalbumin cDNA (pCI-OVA).
The vector pCI-OVA has been generated by inserting the OVA-cassette amplified from DEC205-OVA (Loschko et al., 2011) into the pCI-neo vector (Promega #TB215) at the NheI-NotI-site. CT26 cells were transfected with an expression vector encoding ovalbumin along with EGFP (pCI-OVA-IRES-GFP) and described previously (Gamrekelashvili et al., 2007) . Stable clones were selected with medium containing 1.5 mg/ml geneticin (Thermo Fisher Scientific) and termed OVA-CMT or OVA-CT26. Stable knockdown of Stat3 was achieved by transfection of OVA-CMT or OVA-CT26 cells with pcDNA6.2-Stat3-miRNA (containing a synthetic Stat3-binding pre-miRNA: TCGTGAAACGTGAGCGACTCAAACTGGTTTTGGCCACTGACTGACCAGTTTGACGCTCACGTTT; target sequence: CAGTTTGAGTCGCTCACGTTT) or pcDNA6.2-scrambled from BLOCK-it Pol II miR RNAi Expression Vector Kit (Thermo Fisher Scientific #K493600), after removal of the EmGFP-expression cassette according to the manufacturer's instructions. Clones were selected using supplemented DMEM containing 10 mg/ml blasticidin S (Thermo Fisher Scientific) and successful knockdown of Stat3 protein was confirmed by immunoblot analysis. For siRNA-mediated knockdown-experiments a pool of 4 pre-validated siRNAs (''ON-TARGETplus-smart pool'') per gene was purchased from Dharmacon/GE Healthcare (Buckinghamshire, UK) and transfected using Viromer green (Lipocalyx, Halle, Germany) or DharmaFECT 4 (Dharmacon) according to manufacturer's instructions. In T cell activation assays OVA-CMT cells were pretreated with H 2 O 2 at 1 mM, E64d (10 mg/ml) or DMSO (all Sigma-Aldrich) for 2 hr at 37
C and washed in cell culture medium. Then 5x10 4 OVA-CMT cells were added to 5x10 5 OT-I splenocytes into a 96-well plate and incubated at 37 C for 2 days. IFNg levels in supernatants were determined by ELISA (DY485, R&D Systems) according to the manufacturer's instructions.
In co-culture experiments using purified DC and CD8 + T cells, DC were prepared from the spleen of C57B/6 wild-type or Tap1 À/À mice 14 days after s.c. injection of 5x10 6 Flt3L-expressing B16 melanoma cells (Mach et al., 2000) or from BALB/c wild-type mice. DC were labeled with a biotinylated CD11c-antibody (553800, BD) and sorted using MACS-separation columns (Miltenyi, BergischGladbach, Germany) according to the manufacturer's instructions. Splenic OT-I CD8 + T cells were magnetically purified by negative selection using CD8a + T cell isolation kit II (130-095-236, Miltenyi). Purity was confirmed by flow cytometry and found to be greater than 95%. For quantification of LMP, cells were incubated in DMEM (Thermo Fisher Scientific) supplemented with 10% FCS and 1% Penicillin-Streptomycin in presence or absence of H 2 O 2 (Sigma-Aldrich) at 1 mM for 2 hr. Then the cells were washed and cultured in supplemented DMEM for another 6 hr. Then cells were detached using Trypsin-EDTA (Thermo Fisher Scientific), and incubated with 50 ng/ml acridine orange (Calbiochem/Merck, Darmstadt, Germany) in supplemented DMEM for 15 min. at 37 C. Then cells were washed in PBS and analyzed by flow cytometry at 488 nm excitation and 620 ± 30 nm emission to quantify the red fluorescence of the lysosomal compartment. Where indicated cells were pre-incubated with rotenone (25 mM), antimycin A (100 mM) or DMSO overnight and with DFO (1 mM, all Sigma-Aldrich) for 1 hr prior to H 2 O 2 -stimulation.
All cell lines have been maintained at 37 C in 5% CO 2 .
Metabolic analyses
Cathepsin activity was measured using cytosolic fractions generated as stated above in presence of pefabloc (1 mM). Assay was performed in triplicates in a reaction buffer (50 mM sodium acetate, 8 mM EDTA, 1 mM DTT, 1 mM pefabloc, all Sigma-Aldrich) using 2 mg of protein lysate and 10 mM protease substrate z-LR-AMC (ES008, R&D Systems). Increase of fluorescence was measured at 390/485 nm on a spectrophotometer (Fluostar Omega, BMG Labtech, Ortenberg, Germany) and slope (DE/t) was calculated at linear phase. Iron content was assessed by confocal live cell microscopy of cells grown on chambered optical coverslips (m-slides, Ibidi, Martinsried, Germany) incubated in phenol-red free medium in presence of the Fe 2+ -sensitive probe IP-1 at 20 mM and Hoechst 33342 (Sigma-Aldrich) at 1 mg/ml and, where indicated, with LysoTracker red DND-99 (Thermo Fisher Scientific) at 25 nM for 30 min. Where indicated cells were pre-treated overnight with rotenone (25 mM), antimycin A (100 mM) or DMSO (all Sigma-Aldrich).
The oxygen consumption of trypsinized OVA-CMT93 scr and OVA-CMT93 STAT3KD cells was determined at 37 C using an Oxygraph2k (Oroboros, Innsbruck, Austria). In each case, 3x10 6 cells were suspended in 2 mL pre-warmed FCS-supplemented DMEM medium and transferred into one of the two Oxygraph-chambers. 10 synchronous measurements with both cell lines were performed. Oxygen consumption rates (OCR) were determined after stabilization of the flux signal (1 st deviation of the change in oxygen concentration) by using the 'mark tool' of the DatLab5 control software (Oroboros). After recording the basal respiration (basal OCR), oligomycin (Sigma-Aldrich) (2 mg/ml) was added to inhibit mitochondrial adenosine-triphosphate (ATP) synthesis. Subsequently carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP, Sigma-Aldrich) was added stepwise to assess maximal capacity of the mitochondrial electron-transfer chain (maximal OCR) that occurred usually at 4.5 -5.5 mM of the uncoupler. Finally, 2 mM KCN (Sigma-Aldrich) was added to determine the mitochondria-independent oxygen consumption of the cells. In order to quantify the glucose uptake 5x10 5 cells were incubated in supplemented DMEM in presence of 5 mg/ml glucose for 24 hr. Then glucose concentration in the supernatant was assayed using the Glucose Assay Kit (Sigma-Aldrich) according to the manfacturer's instructions and substracted from initial concentration. Total cellular adenosine-triphosphate (ATP) content was measured using the kit CellTiter-Glo (Promega, Madison, USA) according to the manufacturer's instructions using 5x10 4 cells.
Cell proliferation was assayed by seeding 10 4 OVA-CMT93 cells and counting the cell number using an automated cell counter (CASY, Roche Innovatis, Reutlingen, Germany) after 84h culture in glucose and pyruvate-free DMEM (Thermo Fisher Scientific) supplemented with 10% FCS and glucose (5 mg/ml), galactose (5 mg/ml), 2-deoxyglucose (1,5 mg/ml) or 3-bromopyruvate (100 mM, all Sigma-Aldrich) as indicated.
Mitochondrial content of cells was measured by flow cytometry following incubation of cells with MitoTracker deep red (250 nM, Thermo Fisher Scientific) in conventional cell culture medium for 30 min at 37 C. To estimate the mitochondrial membrane potential cells were incubated with tetramethylrhodamin-methylester (TMRM, 50 nM) in HBSS supplemented with 10 mM HEPES (all Thermo Fisher Scientific) for 30 min at 37 C and subjected to flow cytometry. MitoTimer was expressed in OVA-CMT scr or OVA-CMT Stat3KD cells by co-transfecting cells with pTRE-Tight-MitoTimer (Hernandez et al., 2013) and pES.1-2(M2N)p (containing reverse tetracycline-responsive transactivator M2) (Urlinger et al., 2000) using Lipofectamine 2000 (Thermo Fisher Scientific) according to the manufacturer's instructions. 2 days after transfection cells were seeded in triplicates, treated with doxycycline (Sigma-Aldrich) at 2 mg/ml for 1 hr, then incubated for additional 48 hr in conventional cell culture medium and treated with doxycycline for 2 hr. Cells were then analyzed by flow cytometry for fluorescence at 530/30 nm and 585/ 42 nm at excitation of 488 nm for new and old mitochondria, respectively. NAD + /NADH ratio was measured using fresh tissue of small intestine and the NAD/NADH Assay Kit (ab65348, Abcam) according to the manufacturer instructions. Citrate synthase activity was assayed using mitochondria isolated from small intestine epithelial cells resuspended in 0.25 M sucrose, 10 mM Tris, 1 mM EDTA, ph 7.2 passed 15 times through a 21G-needle. Unbroken cells were pelleted at 750 g for 5 0 and discarded. The supernatant was subjected to centrifugation at 9,000 g for 15' and the pellet resuspended in 0.25 M sucrose, 2 mM HEPES, 0.1 mM EGTA, pH 7.4 (with KOH) and used as crude mitochondrial fraction. To release matrix enzymes mitochondria were pelleted at 10,000 g for 15' and resuspended in 25 mM potassium phosphate buffer, pH 7.2, 5 mM MgCl 2 and subjected to 3 freeze-thaw cycles. The assay was performed adding acetyl CoA (0.1 mM) and oxaloacetic acid (0.1 mM) in buffer containing 50 mM KPi, pH 7.4, 0.1 mM 5,5 0 -dithio-bis-(2-nitrobenzoic acid) (DTNB, all Sigma-Aldrich or Carl Roth) and slope (DE/t) was measured at 412 nm using a spectrophotometer (SpectraMax 340, Molecular Devices, Sunnyvale, USA).
RNA Analysis
Total RNA was extracted from snap-frozen tissue, isolated enterocytes or cultured cells using a RNeasy Mini Kit (QIAGEN, Hilden, Germany) according to the manufacturer's instructions. SuperScript II Reverse Transcriptase (Thermo Fisher Scientific) was used for synthesis of cDNA. Real-time PCR analysis using Fast-Start Universal SYBR Green PCR Master Mix (Roche Diagnostics) was performed on a StepOne Plus Real-Time PCR System (Thermo Fisher Scientific). Data has been normalized to the mRNA level of a housekeeping gene (cclophilinA) using the delta C T method (2 CTcyclo-CTgene ). Primer sequences are listed in Table S1 .
NGS-based TCR repertoire analysis NGS-based TCR repertoire analysis was performed by Repertoire Genesis (Osaka, Japan). Total RNA was converted to complementary DNA (cDNA) with Superscript III reverse transcriptase (Thermo Fisher Scientific). BSL-18E primer containing polyT 18 (see below) and a SphI site was used for cDNA synthesis. After cDNA synthesis, double strand (ds)-cDNA was synthesized with E. coli DNA polymerase I, E. coli DNA Ligase, and RNase H. ds-cDNAs were blunted with T4 DNA polymerase (all Thermo Fisher Scientific). P10EA/ P20EA adaptor was ligated to the 5 0 end of the ds-cDNA and then cut with SphI restriction enzyme. After removal of adaptor and primer with MinElute Reaction Cleanup kit (QIAGEN), PCR was performed with KAPA HiFi DNA Polymerase (Kapa Biosystems, Woburn, USA) using either TCR a chain constant region-specific (mCA1) or TCR b-chain constant region-specific primers (mCB1) and P20EA (Table S1 ). PCR conditions were as follows: 98 C (20 s), 65 C (30 s), and 72 C (1 min) for 20 cycles. The second PCR was performed with either mCA2 or mCB2 and P20EA primers using the same PCR conditions. Amplicons were prepared by amplification of the second PCR products using P22EA-ST1-R and either mCA-ST1-R or mCB-ST1-R. After PCR amplification, index (barcode) sequences were added by amplification with Nextera XT index kit v2 setA (illumina, San Diego, USA). The indexed products were mixed in an equal molar concentration and quantified by a Qubit 2.0 Fluorometer (Thermo Fisher Scientific). Sequencing was done with the Illumina Miseq paired-end platform (2 3 300bp). Assignment of sequences was performed by determining sequences with the highest identity in a dataset of reference sequences from the international ImMunoGeneTics information systemâ (IMGT) database (http://www.imgt.org). Data processing, assignment, and data aggregation were automatically performed using repertoire analysis software originally developed by our group (Repertoire Genesis, RG). RG implemented a program for sequence homology searches using BLATN, an automatic aggregation program, a graphics program for TRV and TRJ usage, and CDR3 length distribution. Sequence identities at the nucleotide level between query and entry sequences were automatically calculated. Nucleotide sequences of CDR3 regions ranged from conserved Cysteine at position 104 (Cys104) of IMGT nomenclature to conserved Phenylalanine at position 118 (Phe118) and the following Glycine (Gly119) was translated to deduced amino acid sequences. Sequence read having identical TRV, TRJ and deduced amino acid sequence of CDR3 was defined as unique read. The copy number of unique reads were automatically counted by RG software in each sample and then ranked in order of the copy number. Percentage occurrence frequencies of sequence reads with TRAV, TRAJ, TRBV and TRBJ genes in total sequence reads were calculated.
QUANTIFICATION AND STATISTICAL ANALYSIS
Please refer to the Figure Legends or the Experimental Details for description of sample size and statistical details. Cell culture assays have been performed in triplicates and in two independent experiments, unless stated otherwise. Data are expressed as mean ± SEM. Differences were analyzed by log-rank, two-tailed Student's t test, Mann-Whitney U test, one-way ANOVA (using Bonferroni post test), one-sample t test or c
